| FSMLX | WCMNX | FSMLX / WCMNX | |
| Total Expense Ratio | 0.66 | 1.24 | 53% |
| Annual Report Gross Expense Ratio | 0.66 | 2.04 | 32% |
| Fund Existence | 13 years | 7 years | - |
| Gain YTD | 10.007 | 9.225 | 108% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 1000 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.48B | 52.4M | 4,740% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 18.98 | 25.42 | 75% |
| Returns for 3 years | 47.50 | 31.21 | 152% |
| Returns for 5 years | -7.73 | -1.40 | 552% |
| Returns for 10 years | 66.89 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| DPG | 14.15 | 0.02 | +0.14% |
| Duff & Phelps Utility and Infrastructure Fund | |||
| PFIG | 23.94 | N/A | +0.01% |
| Invesco Fdmtl Invmt Grd Corp Bd ETF | |||
| FLDZ | 30.41 | N/A | N/A |
| RiverNorth Patriot ETF | |||
| CRSH | 20.94 | -0.20 | -0.96% |
| Yieldmax Short Tsla Option Income Strategy ETF | |||
| IBB | 164.27 | -5.10 | -3.01% |
| iShares Biotechnology ETF | |||